Cigna Investments’s Argan AGX Stock Holding History

Cigna Investments’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,332	Closed	-$380K	–	884
2017 Q2	$380K	Buy	+6,332	New	+$409K	0.03%	548

Other funds holding AGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Cigna Investments's AGX Position: Q3 2017 in Review

Cigna Investments sold out of Argan (AGX) in Q3 2017, closing a stake of 6,332 shares — an estimated $380K sold.

Cigna Investments first reported a position in AGX in Q2 2017 and held it in 1 quarter. The position peaked at $380K in Q2 2017. 184 funds tracked by Wall St. Rank hold AGX as of Q3 2017.

Cigna Investments reported no remaining Argan position as of Q3 2017 after selling out during the quarter.
Cigna Investments sold 6,332 Argan shares in Q3 2017, an estimated $380K.
Cigna Investments first reported a position in Argan in Q2 2017 and held it in 1 quarter.
Cigna Investments's Argan position peaked at $380K in Q2 2017.
184 funds tracked by Wall St. Rank held Argan as of Q3 2017.

Based on Cigna Investments's 13F filing for Q3 2017, filed 11 Oct 2017.